Apparatus and method for creating constraint within gastrointestinal tract organ

通过在胃肠道器官中使用接合和瘢痕形成装置改变器官壁的形状和特性,形成瘢痕组织以固定器官,解决了现有减肥手术效果暂时和侵入性大的问题,实现了更持久的体重减轻 and safe treatment for obesity.

CN118973505APending Publication Date: 2024-11-15BARIATEK MEDICAL
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202380030475.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-07
Filing Date
2023-03-07
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing bariatric surgery such as sleeve gastrectomy has temporary and invasive effects, resulting in weight rebound, and endoscopic surgery is not lasting, making it impossible to provide a continuous treatment solution for obesity.

Method used

An instrument and method is designed to change the shape and characteristics of the organ wall by forming constraints in the gastrointestinal organs, using engaging devices and scar formation devices to form scar tissue to fix the organs, reduce their size and mobility, and combine them with fixation. The device fixes the organ within a small size to avoid weight rebound.

Benefits of technology

A longer-lasting weight loss effect is achieved, reducing the risk of motility and expansion of the organs, avoiding damage to non-target tissues, and improving the durability and safety of bariatric surgery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118973505A_ABST
    Figure CN118973505A_ABST
Patent Text Reader

Abstract

An instrument for creating a constraint in a gastrointestinal tract organ, optionally the stomach, which instrument can be configured to be insertable into the interior of the organ, said instrument comprising at least two, optionally at least three, optionally all of the following:-engagement means (20) for engaging and manipulating organ wall tissue to displace tissue, optionally by pulling and / or folding and / or rolling up the tissue; -a scarring device (30) for forming scarred tissue, optionally displaced tissue; means for delivering the spacer (40) and / or the isolator to the organ wall tissue, optionally to the displaced and / or engaging tissue and / or tissue within the operating range of the scarring device; -a securing device for optionally inserting one or more tissue securements in the scar region of the tissue.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] In one non-limiting aspect, the present invention relates to forming a restriction in an organ of the gastrointestinal tract. The organ may be the stomach. Background Art

[0002] Obesity is a major problem in today's society, with 13% of the world's population being obese and 39% being overweight. When other treatments fail, bariatric surgery is one of the most promising approaches to treat these difficult conditions.

[0003] Although great strides have been made in the field of bariatric surgery, there are still many complex issues that need to be addressed in order to provide patients with satisfactory and lasting results.

[0004] For example, it is well known that sleeve gastrectomy surgery can help patients lose weight, but due to the dilating nature of gastric tissue, the so-called weight loss is only temporary in most cases. Therefore, it is only a temporary solution and may cause patients to regain weight in the long term. In addition, sleeve gastrectomy surgery is a very invasive procedure in which a large part of the stomach is surgically removed, so the recovery time is long. Although less invasive endoscopic procedures have been proposed, these procedures are generally less lasting and less effective than surgical procedures.

[0005] US2017020592 Al proposes a surgical procedure performed after failed bariatric surgery and includes ablating tissue at the surgical site of the previous surgery.

[0006] US2017367723 A relates to a method of ablating growth hormone producing cells to reduce the production of the hunger hormone growth hormone. More specifically, the method involves cell death of AX-type cells in the stomach of a patient. Summary of the invention

[0007] The present invention is intended to improve patient outcomes and increase the diversity of treatment methods and devices available for sustained weight loss in obese patients.

[0008] A first aspect of the invention provides an apparatus for forming a restriction in a gastrointestinal organ. The organ may optionally be the stomach. The device may be inserted into the interior of the organ, optionally through a natural body opening.

[0009] The apparatus may include means for displacing a tissue region of the organ wall from within the organ to change the shape of the organ wall.

[0010] The apparatus may also include means for forming scar tissue in a target area at or adjacent to the displaced tissue area to alter wall tissue properties in the target area to affect and / or support constraint.

[0011] The term "scar" may be understood as intentionally causing tissue damage so that one or more scars may form or appear on the tissue after the wound heals.

[0012] The engagement device may be configured for insertion into a patient's body, optionally through a natural opening of the patient.The engagement device may carry a scarring device for forming scar tissue in a target area.

[0013] Furthermore, the engagement device may include one or more engagement ports for allowing manipulation of one or more engagement devices and / or scarring devices.

[0014] In some embodiments, the engagement device can be configured to engage with a portion of the organ wall from the inside of the organ for pulling and / or constraining a portion of the organ wall inwardly and / or outwardly. Alternatively, the engagement device can be configured to pull at least a portion of the organ wall (e.g., toward the engagement device) for changing the position of the portion of the wall, e.g., inwardly and / or outwardly.

[0015] The engagement device can allow the organ wall to maintain a distance from the surrounding tissue. It can also allow the organ to be manipulated into a desired structure or shape. This advantage may further help avoid damage to non-target tissue during surgery. In some embodiments, a spacer can be optionally provided to space and / or isolate the target tissue from the non-target tissue, also helping to avoid damage to the non-target tissue. More details of this spacer will be described below.

[0016] In some embodiments, the engagement device may provide an engagement element or a plurality of engagement elements for displacing a portion of the organ wall. Optionally, the engagement element may be operable via one or more engagement ports of the engagement device.

[0017] The engaging elements may, for example, include one or more suction elements selected for sucking a portion of the organ wall by negative pressure; one or more spiral screws for screwing into the organ wall; and a clamping ring for fastening the organ wall.

[0018] In some embodiments, the engagement device may also be configured to at least partially rotate to form a constraint on the organ.

[0019] Alternatively, the rotation of the engagement device can result in a rotation of the organ wall engagement portion. The rotation can cause the organ wall to at least partially roll up, fold up. Further alternatively, the rotation can result in the rolling up of the organ wall around the engagement device. This can constrain the size of the organ and / or keep the organ or a portion of the organ away from the surrounding tissue.

[0020] The engaging device can, for example, rotate at least 180°, optionally at least 270°, optionally at least 360°, optionally at least 720° to roll up or wrap the portion of the grasped tissue. The engaging device can perform, for example, a rotation of up to 720° or more to reduce the size of an organ.

[0021] The device may be configured to displace at least a portion of an organ wall according to (but not limited to) any combination of the above embodiments.

[0022] The present invention may also provide a device for forming scar tissue in a target area to change the wall tissue properties in the target area. The target area may be located at or adjacent to the displaced tissue area. This may help to influence and / or support the restriction of the organ.

[0023] The scarring device may be configured to injure the organ wall such that scar tissue formation may be promoted.

[0024] Scar tissue is generally defined as tissue that forms when a wound is repaired. Scar tissue is also defined as having properties that are different from normal tissue, for example, scar tissue is harder and stiffer than normal tissue, and scar tissue may also shrink over time.

[0025] Additionally or alternatively, the scarring device may scar portions of the organ wall that are in close proximity to each other. This may result in one or more adhesions being formed between portions of the organ wall.

[0026] Adhesions can be understood as bands of scar-like tissue that form between two surfaces inside the body and stick them together.

[0027] Thus, promoting the formation of scar tissue and / or adhesions of the organ wall may help reduce the mobility of the organ wall and may help secure the organ in a constrained structure.

[0028] In some embodiments, the scarring device can be configured to thermally damage the organ wall. For example, the scarring device can use a caustic and / or a cauterizing agent.

[0029] Alternatively, the scarring device may cause thermal damage to the organ wall via laser and / or radiofrequency treatment.

[0030] In some embodiments, the scarring device may be operated after operation of the engagement device and / or simultaneously with operation of the engagement device. Additionally or alternatively, the scarring device and the engagement device may be operated in an alternating manner.

[0031] In some embodiments, it may be desirable to form a scar in one or more areas of the displaced tissue portion. Additionally or alternatively, it may be desirable to form a scar in a different portion of the organ wall than the portion that may have been displaced.

[0032] Scarring of one or more regions of the organ wall can reduce the mobility of the organ. In addition, it can also promote organ atrophy or fusion of multiple parts of the organ wall. Damaging the organ wall once the joint device is operated can avoid causing additional damage, such as damage to surrounding non-target tissue.

[0033] In a second aspect, the invention provides, optionally in combination with the first aspect, a fixation device for placing one or more tissue engaging fixation elements and / or tissue penetrating fixation elements. Optionally, the fixation elements are placed in an area of ​​tissue damaged by a scar tissue forming device.

[0034] The fastener may be configured to secure the organ in a reduced size. Alternatively, the fastener may secure the rolled folds of the organ. Placing the fastener in the damaged area of ​​the organ wall may prevent the fastener from being subjected to excessive tension, thereby helping to prevent the fastener from falling off or breaking.

[0035] The fixing means can be any means suitable for fixing the organ in a smaller size. For example, the fixing means can be sutures, cotton wool, staples.

[0036] The reduction in scar tissue mobility, optionally combined with the placement of fixation devices, can avoid postoperative organ distension and thus make the surgical results of treating obesity more durable.

[0037] In some embodiments and according to any aspect of the present invention, the engagement device can also be configured to break away from the engagement portion of the organ wall, so that the apparatus can be taken out from the patient. For example, the engagement device can break away from the grasped tissue portion by applying positive pressure. Alternatively, the use of positive pressure can keep the organ wall away from the device, and thus facilitate taking out. In addition, for example, the engagement device can break away from the organ wall portion by unscrewing the spiral screw.

[0038] Additionally or alternatively, the engagement means may be at least partially folded to disengage from the organ wall. This may facilitate removal of the device from the patient.

[0039] The engagement device may have a first operative configuration for repositioning and / or damaging an organ wall and a second folded configuration for inserting and / or removing the instrument from a patient.

[0040] Devices provided herein may be configured to promote scarring of at least one region of an organ wall to reduce the size and / or motility of the organ.

[0041] A third aspect of the invention provides a method of forming a restriction in a gastrointestinal organ. The organ may optionally be the stomach. The method may optionally use a device as described above.

[0042] The method may include the step of inserting the engagement device into the patient's body, optionally through a natural body opening.

[0043] The method may include the step of activating the engagement device to change the shape of the organ, such as by displacing organ wall tissue. In some embodiments, activating the engagement device may change the shape of the organ by pulling and / or pushing a portion of the organ wall. Alternatively, the engagement device may be activated to pull a portion of the organ wall inwardly.

[0044] Additionally or alternatively, the method may provide the step of activating the engagement device to manipulate the organ wall tissue into a rolled fold.

[0045] Additionally or alternatively, the method may provide the step of deploying a spacer in the region of the displaced organ wall tissue to space and / or isolate the displaced organ wall tissue from surrounding tissue.

[0046] Additionally or alternatively, the method may provide the step of operating the scarring device to modify at least one region of organ wall tissue, optionally modifying a target region adjacent to a portion of the organ wall tissue engaged by the engagement device.

[0047] Alternatively, the step of activating the engagement means and the step of activating the scarring means may be performed simultaneously with each other, or one after the other, or in an alternating sequence.

[0048] Furthermore, the method may additionally or alternatively provide the step of activating the fixation device to place one or more fixation elements in the injury target area of ​​the organ wall tissue.

[0049] A fourth aspect of the present invention, optionally in combination with any of the preceding aspects, provides at least two, optionally all three of the following:

[0050] - an engagement device for engaging and manipulating organ wall tissue to displace the tissue (optionally by pulling and / or folding and / or rolling the tissue);

[0051] - a scarring device for forming scar tissue (optionally displaced tissue);

[0052] - Fixation means for inserting one or more tissue fixation elements (optionally in a scarred area of ​​tissue).

[0053] The fourth aspect specifically contemplates that, in one form, at least engagement means and scarring means are included; and in another form, at least scarring means and fixation means are included.

[0054] A fifth aspect of the present invention, optionally in combination with any of the preceding aspects, provides a method comprising at least two, optionally all three of the following:

[0055] - a joining step, joining and manipulating the organ wall tissue to displace the tissue (optionally by pulling and / or folding and / or rolling the tissue);

[0056] - a scarring step, forming scar tissue (optionally displaced tissue);

[0057] - A fixation step, inserting one or more tissue fixation elements (optionally in a scarred area of ​​the tissue).

[0058] The fifth aspect specifically contemplates: in one form at least a joining step and a scarring step; and in another form at least a scarring step and a fixation step.

[0059] In a sixth aspect of the invention, optionally in combination with any of the preceding aspects, the apparatus may comprise or may further comprise means for delivering a spacer to the engagement and / or displacement portion of the organ wall. Optionally, the means for delivering the spacer may be integrated into the engagement means.

[0060] The spacer can be delivered in such a way that it at least partially surrounds the junction of the organ wall. For example, the spacer can be configured to be at least temporarily placed around the junction of the organ wall so that the two sides of the junction of the wall at least partially become closer and / or remain closer.

[0061] The spacer may be any suitable means for forming a separation between the target tissue and the non-target tissue so that the use of a scarring device on the target tissue does not affect the non-target tissue. For example, the spacer may be a thermal isolator to hinder the transfer of thermal energy to the non-target tissue.

[0062] In some embodiments, the thermal insulator can be delivered to the engaging portion of the organ wall through a port of the engaging device. Alternatively, it can be delivered to the engaging portion of the organ wall within the engaging device. For example, if a portion of the organ wall is pulled into the engaging device through the engaging element.

[0063] For example, a thermal isolator may be placed prior to use of a scarring device, which is optionally configured to thermally damage the organ wall.

[0064] Thermal isolators can prevent non-target tissue from being damaged by the use of caustic and / or ablative agents.

[0065] Additionally or alternatively, thermal isolators may prevent laser and / or radiofrequency therapy from being transmitted to non-target tissue.

[0066] In some embodiments, the thermal isolator can be a cooling balloon configured to prevent thermal energy from being dissipated to non-target tissue. The cooling balloon can be at least partially annular for limiting the joint and / or displacement of the organ wall. The balloon can be configured to contain and / or circulate a fluid, preferably a cooling fluid for preventing thermal energy from being transmitted to non-target tissue.

[0067] Additionally or alternatively, the spacer may be inflatable to increase the physical isolation distance when inflated. The inflation fluid may be, for example, a coolant fluid as described above.

[0068] An advantage of a thermal isolator is that it provides an insulating separation between target tissue and non-target tissue and can thereby reduce the risk of inadvertent damage to surrounding tissue.

[0069] Although certain features and aspects have been summarized above, this does not limit the scope of protection. Any novel features and / or ideas disclosed herein and / or shown in the accompanying drawings, whether or not emphasized, should be protected. BRIEF DESCRIPTION OF THE DRAWINGS

[0070] Non-limiting embodiments will now be described, by way of example only, and with reference to the accompanying drawings, in which:

[0071] Figure 1 is a schematic perspective view of one embodiment of a gastrointestinal tract injury device;

[0072] Figure 2a -d is a schematic diagram showing a first embodiment of using an apparatus for damaging the gastrointestinal tract;

[0073] Figure 3 is a schematic flow chart of a first general method of use;

[0074] Figure 4 is a schematic flow chart of a second general method of use;

[0075] Figure 5 is a schematic flow chart of a third general method of use.

[0076] Figure 6a -h is a schematic diagram showing a second embodiment of using the device for injuring the gastrointestinal tract.

[0077] Figure 7a -f is a schematic diagram showing a third embodiment of using the device for damaging the gastrointestinal tract.

[0078] Figure 8 is a schematic flow chart of a fourth general method of use. DETAILED DESCRIPTION

[0079] See also Figure 1The device 10 provides an instrument body 11 configured to be inserted into a patient's body and includes a working area 20 (e.g., a working end), the working area 20 providing a plurality of engagement devices 21 and a scarring device 30. The engagement devices 21 are operable to cause engagement between the working end 20 and a portion of an organ wall. For example, the engagement devices 21 may be or include a suction port for applying negative pressure to draw tissue onto the body 11, or other positive engagement devices. One or more engagement devices 21 may be provided entirely within the working end 20, or a portion of one or more engagement devices 21 may be provided elsewhere. For example, a negative pressure generator may be provided or coupled to the device externally.

[0080] The scarring device 30 is configured to cause damage and / or scarring to at least one area of ​​the organ wall. For example, the scarring device may include a device for applying energy to the tissue or generating energy (e.g., heat) within the tissue to thermally damage the tissue. The scarring device may include a laser and / or a radio frequency electrode and / or an argon plasma. The laser and / or radio frequency energy and / or argon plasma may be generated within a portion of the instrument within the body, or supplied to the instrument working end 20 from outside the body. Although the scarring device 30 is shown as part of the same instrument as the engagement device 21, in other embodiments, the scarring device 30 may be a separate or separately introduceable instrument.

[0081] See also Figure 2a -d, in an exemplary method of use, the working end 20 of the instrument 10 is inserted into an organ 60, such as an organ of the gastrointestinal tract. The organ 60 may be the stomach. The instrument 10 may be inserted through a natural body opening (such as the mouth) to access the organ 60.

[0082] The instrument 10 is operated so that the working end 20 engages a portion of the organ wall tissue via one or more engagement devices 21 (see Figure 2a In a first rotation step, the working end 20 is rotated, for example, by 360°, thereby rolling up the tissue of the organ wall to be engaged (see Figure 2b In the next step, the working end 20 is further rotated to 720° and produces rolled-up folds of the organ wall (see Figure 2c ). In the illustrated embodiment, the tissue is rolled outward to form a fold or bulge on the outside of the organ, but in other embodiments, the tissue may be rolled inward to form a fold or bulge on the inside of the organ.

[0083] At any one or more stages of the rotation / rolling process, the scarring device 30 may be operated to create a scar in the tissue wall. For example, the scarring device 30 may be operated after the first rolling step and / or after the second rolling step. Alternatively, each rolling step may be performed as a sequence of multiple sub-steps, and the scarring device 30 may be operated after each sub-step.

[0084] exist Figure 2d In one embodiment, the engagement device is disengaged and the working end 20 is removed from the rolled, wrinkled tissue. In one form, positive pressure can be applied through the port previously used as the suction port to effectively release the working end 20 from the tissue wrapped around the working end. In another form, the working end 20 can be at least partially radially folded to provide additional space for releasing the working end 20 from the tissue wrapped around the working end.

[0085] The above method provides many advantages for forming size constraints in the organ 60. Scarring of tissue can shrink the tissue and thus reduce the organ volume. Scarring can also reduce the motility of the tissue. Taking the stomach organ 60 as an example, scarring can also reduce the production of gastric juice in the damaged tissue, thereby helping to cause the desired reduction in gastric function.

[0086] In addition to scarring or as an alternative, one or more engagement devices 21 enable tissue to be rolled up to reduce organ volume. Additionally or alternatively, one or more engagement devices enable organ wall tissue to be pulled away from other adjacent body organs, thereby significantly reducing the risk of accidental damage to other organs caused by the operation of the scarring device 30.

[0087] Although not explicitly shown, the instrument may also include a fixing device for applying one or more tissue penetrating fixings to the rolled tissue. The fixing device may form part of the working end 20 of the instrument 11, or it may be a separate device that can be introduced into the tissue after the instrument working end 20 is removed. The tissue penetrating fixings can fix the scarring tissue in a rolled form. Exemplary tissue penetrating fixings include one or more sutures, one or more cotton wool, or one or more insertable anchors.

[0088] The reduced mobility and regenerative capacity of scar tissue can provide a stable environment for the secure attachment of fasteners. Compared with intact tissue, this tissue has a significantly reduced tendency to release or expel fasteners embedded in the tissue.

[0089] By example, Figures 3 to 5 The general method described herein is shown.

[0090] Figure 3A first exemplary method is shown, including a manipulation step 70 of engaging and manipulating organ wall tissue from within the organ to displace the tissue, for example, by pulling and / or rolling and / or folding the tissue. A scarring step 72 includes scarring the tissue using a scarring device 30, for example, scarring an area of ​​displaced tissue or an area adjacent to the displaced tissue. The method can be repeated multiple times to gradually displace and scar the organ wall tissue.

[0091] Figure 4 A second exemplary method is shown including a scarring step 72 to intentionally damage organ wall tissue. A fixation step 74 includes applying one or more tissue penetrating fixation elements to the scar tissue.

[0092] Figure 5 A third exemplary method is shown, comprising a manipulation step 70 as described above, a scarring step 72 as described above, and a fixation step 74 as described above, and combining all of the results and advantages of the first and second methods.

[0093] See also Figure 6a -h, In an exemplary method of use, the working end 20 of the instrument 10 is inserted into an organ 60, such as an organ of the gastrointestinal tract. Optionally, the instrument 10 is inserted through a natural body opening, such as the mouth. The organ 60 may be the stomach.

[0094] exist Figure 6b -d, the instrument 10 is operated to engage the working end 20 with a portion of the organ wall tissue through one or more engagement devices 21. The instrument 10 is operated to pull the engaged tissue to form a bulge inside the organ. The delivery device is operated to deliver a spacer and / or a separator 40 (hereinafter referred to as a spacer / separator) to the engaged portion of the organ wall. The spacer / separator 40 is delivered so as to at least partially limit the engaged portion of the tissue and bring the two sides of the engaged tissue closer to each other or keep the two sides of the engaged tissue closer to each other.

[0095] The delivery device may form part of the working end 20 of the instrument 11, or it may be a separate device that can be introduced into tissue.

[0096] like Figure 6e As shown, the presence of the spacer / isolator 40 keeps the joined portions of the tissue in an at least partially spherical structure. In the illustrated embodiment, the spacer / isolator can be a thermal isolator to provide a thermal barrier to protect the tissue behind the thermal isolator from damage during scar formation. The thermal isolator can be provided, for example, by a thermally insulating material and / or a heat dissipating material and / or a cooling device (e.g., cooling by circulation of a coolant fluid, which will also be shown in the next embodiment).

[0097] In the illustrated embodiment, the spacer / spacer 40 can remain on the tissue after surgery, for example, to serve as a tissue fixation device. Alternatively (and as shown in more detail in the next embodiment, the spacer / spacer 40 can be removed after surgery).

[0098] See also Figure 6f -h, operating the scarring device 30 to produce a scar in the tissue wall. The scarring device 30 is configured to adapt to the structure of the target tissue. For example, Figure 6f As shown, the scarring device 30 takes the generally spherical shape of the target tissue that is secured by the spacer 40. Due to the spacer 40, the damage caused by the scarring device 30 is confined to the target tissue.

[0099] like Figure 6h As shown, once healed, the tissue damaged by the scarring device heals and contracts, resulting in organ restraint.

[0100] Figure 7a -f shows the Figure 6a -h Another similar exemplary method of use uses a separator and / or spacer (separator / spacer) 40. In this example, the separator / spacer 40 is temporarily placed and removed after the operation. See Figure 7a , the spacer / isolator 40 includes a conduit 42 defining a loop. In one form, the conduit allows a coolant fluid to circulate, actively cooling adjacent tissue by absorbing and removing heat from the circulating coolant. In another form, the conduit 42 allows the spacer to be inflated and / or expanded to expand the conduit into a loop. In another form, the conduit can be both actively cooled and inflated, for example, by using a pressurized coolant fluid.

[0101] See also Figure 7b , similar to the previous embodiments, the working end 20 of the instrument 10 is inserted into an organ 60, such as an organ of the gastrointestinal tract. Optionally, the instrument 10 is inserted through a natural body opening, such as the mouth. The organ 60 may be the stomach. The instrument 10 is operated to engage the working end 20 with a portion of the organ wall tissue via one or more engagement devices 21.

[0102] See also Figure 7c , the instrument 10 is operated to pull the joined tissues to form a bulge inside the organ. Figure 7d, operate the delivery device to deliver the spacer / spacer 40 to the joint portion of the organ wall. The spacer / spacer 40 is delivered to at least partially limit the joint portion of the tissue and bring the two sides of the joint tissue closer to each other or keep them closer to each other. The delivery device can form a part of the working end 20 of the instrument 11, or it can also be a separate device that can be introduced into the tissue. The spacer / spacer 40 can be extended / retracted relative to the delivery device to accommodate the displaced tissue and constrain the tissue to form a ball.

[0103] like Figure 7d As shown, the presence of the spacer / isolator 40 maintains the engaged portion of the tissue in an at least partially spherical structure. In the illustrated embodiment, the spacer / isolator can be a thermal isolator to provide a thermal barrier to protect the tissue behind the thermal isolator from damage during scar formation. As described above, the annular shape allows the circulation of a coolant fluid and / or inflation into the annular shape to increase the physical spacing of the bulb from the tissue behind the spacer / isolator 40, such as Figure 7e shown.

[0104] See also Figure 7f , operating the scarring device 30 to produce a scar in the tissue wall. The scarring device 30 is configured to adapt to the structure of the target tissue. For example, Figure 7f As shown, the scarring device 30 has a generally spherical shape of the target tissue that is secured by a spacer 40. The lesion formed by the scarring device 30 is confined to the target tissue due to the spacer 40. The spacer / spacer 40 can be removed post-operatively, for example, by expanding the ring relative to the delivery device, which enlarges the size of the ring and allows it to be removed from the tissue without hindrance. Figure 8 A fourth exemplary method is shown including a manipulation step 70 as described above, a delivery step 76 for delivering a spacer / spacer to the engaged and / or displaced tissue, and a scarring step 72 as described above.

[0105] It should be understood that the foregoing description is only illustrative of the present invention and that numerous modifications and equivalents may be made within the scope and / or principles of the present invention.

Claims

1. An apparatus for forming a restriction in a gastrointestinal organ, the gastrointestinal organ being optionally the stomach, the apparatus being configured to be insertable into the interior of the organ, the apparatus comprising: means for displacing a region of organ wall tissue from within the organ to alter the shape of the organ wall; as well as A device for forming scar tissue in a target area at or adjacent to a displaced tissue area to change the characteristics of wall tissue in the target area.

2. The apparatus of claim 1, wherein the means for forming scar tissue is configured to form scar tissue to achieve and / or support constraint.

3. An apparatus according to claim 1 or 2, wherein the engagement means is configured to pull at least a portion of the organ wall.

4. The apparatus according to any one of claims 1 to 3, further comprising means for delivering a spacer and / or a separator to the joined and / or displaced portion of the organ wall, the spacer being configured to protect adjacent tissue from damage by the scarring device.

5. The apparatus according to claim 4, wherein: The spacer is a thermal spacer.

6. An apparatus, optionally according to any one of claims 1 to 5, configured to form a restriction in a gastrointestinal organ, optionally the stomach, the apparatus being configured to be insertable into the interior of the organ, the apparatus comprising: A fixation device is provided for placing one or more tissue engaging and / or tissue penetrating fixations in an area of ​​scar tissue.

7. An apparatus, optionally according to any one of claims 1 to 6, configured to form a restriction in a gastrointestinal organ, optionally the stomach, configured to be insertable into the interior of the organ, the apparatus comprising at least two, optionally at least three, optionally all of the following: Engaging means for engaging and manipulating organ wall tissue to displace said tissue, optionally by pulling and / or folding and / or rolling said tissue; scarring means for forming scar tissue, optionally displaced tissue; means for delivering spacers and / or dividers to tissue of the organ wall, optionally to displaced and / or engaged tissue, and / or to tissue within the operative range of the scarring device; A fixation device for inserting one or more tissue fixation members, optionally for inserting one or more tissue fixation members into a scar region of tissue.

8. A method of or for forming a restriction in a gastrointestinal organ, optionally the stomach, the method optionally using an apparatus according to any one of claims 1 to 7, the method comprising at least two, optionally at least three, optionally all of the following steps in any order: operating the engagement device to engage and manipulate the organ wall tissue to displace the tissue, optionally by pulling and / or folding and / or rolling the tissue; operating a scarring device to form scar tissue, optionally scarring displaced tissue; operating the device to deliver spacers and / or dividers to organ wall tissue, optionally to displaced and / or engaged tissue, and / or tissue within the operating range of the scarring device; The fixation device is operated to insert one or more tissue fixation elements, optionally into a scarred area of ​​tissue.

Citation Information

Patent Citations

  • Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and / or recurrent excess body weight following a weight loss operation

    US20170020592A1

  • Endoscopic gastric mucosal ablation / resection / exclusion (a / r / e) as a minimally invasive weight loss approach

    US20170367723A1